Skip to main content

A new pilot project to fight falsified and sub-standard medicines in developing countries

Washington -

Marking a further step in the cooperation between SICPA and International Organizations, Anne-Marie Leroy, Senior Vice President and General Counsel of the World Bank Group, and Pierre Viaud, Senior Director Public Affairs & Government Relations of SICPA, signed during the Law, Justice and Development Week 2015 an agreement confirming SICPA’s contribution to a pilot project developed by the Global Forum on Law, Justice and Development (GFLJD).

This pilot is a preliminary phase of a larger initiative to fight falsified and substandard medicines in developing countries.

Partnering initially with one country, the project will include assessment of national, cross-border and regional legal and regulatory frameworks. The project builds on the knowledge developed by the World Health Organization, other international actors and on international conventions such as the United Nations Convention against Transnational Organized Crime, and the MEDICRIME Convention of the Council of Europe. SICPA, a Swiss-based private company, is a global provider of secured authentication, identification and traceability solutions and services, which recently conceived for the Government of the Republic of Albania a traceability system for pharmaceutical products.

The pilot project will be implemented by the World Bank in collaboration with the United Nations Interregional Crime and Justice Research Institute (UNICRI), the O’Neill Institute for National and Global Health Law at Georgetown University and other GFLJD Partners. The project paves the way for legal support for the fight against falsified and sub-standard medicines in a large number of developing countries.

For more information:

Global Forum on Law, Justice and Development:

International Development Law Organization:

O’Neill Institute on National and Global Health Law:

United Nations Interregional Crime and Justice Research Institute: